CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.17 (-10.18%)
Close on Nov 17, 2026Market cap $22.68MP/E –Yield –
CervoMed enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CervoMed's enterprise value was -$958.57K on Nov 11, 2026, against $64.67M a year earlier. Over the last 5 years it ranged from -$28.00M to $2.33B, with a median of $16.02M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$958.57K | -102.1% |
| 2025 | Dec 31, 2025 | $45.80M | – |
| 2024 | Dec 31, 2024 | -$27.34M | -183.2% |
| 2023 | Dec 29, 2023 | $32.87M | – |
| 2022 | Dec 30, 2022 | -$8.59M | -100.4% |
| 2021 | Dec 31, 2021 | $2.33B | -39.0% |
| 2020 | Dec 31, 2020 | $3.82B | +2347.7% |
| 2019 | Dec 31, 2019 | $156.02M | -68.3% |
| 2018 | Dec 31, 2018 | $492.17M | -61.6% |
| 2017 | Dec 29, 2017 | $1.28B | -26.7% |
| 2016 | Dec 30, 2016 | $1.75B | +25.6% |
| 2015 | Dec 31, 2015 | $1.39B | -69.4% |
| 2014 | Dec 31, 2014 | $4.56B | +381.2% |
| 2013 | Dec 31, 2013 | $946.86M | -26.4% |
| 2012 | Dec 31, 2012 | $1.29B | -55.9% |
| 2011 | Dec 30, 2011 | $2.92B | – |
See a number that looks wrong?